Transaction · 0001628280-26-065566

RIKER LAUREN

RIKER LAUREN, SVP, reported a transaction classified as exercise at Pacira BioSciences, Inc. involving 6000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MSVP
PCRXPacira BioSciences, Inc.
Filing timeOct 09
Trade dateOct 08, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$24.48
Pre-filing
1mo ago +5.7%1w ago +0.0%1d ago +0.0%
Returns since
7d30d90d180d1y

PCRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PCRX since 2026-10-09Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001628280-26-065566
Stock Option (Right to Buy)
Transaction date
Oct 08, 2026
Filed Oct 09, 2026, 11:07 PM · 1d delay
Shares
6.00k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership 10b5-1 Detected
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Senior Vice President, Finance

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exc…

  2. F2

    The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installmen…

Original filing · 0001628280-26-065566
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PCRX